Mechanisms of minocycline-induced suppression of simian immunodeficiency virus encephalitis: inhibition of apoptosis signal-regulating kinase 1

References

• Akterin S, Cowburn RF, Miranda-Vizuete A, Jimenez A, Bogdanovic N, Winblad B, Cedazo-Minguez A. Involvement of glutaredoxin-1 and thioredoxin-1 in beta-amyloid toxicity and Alzheimer's disease. Cell Death Differ 2006; 13: 1454–1465
   PubMed Web of Science ®Google Scholar
• Ances BM, Ellis RJ. Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol 2007; 27: 86–92
   PubMed Web of Science ®Google Scholar
• Barber SA, Uhrlaub JL, DeWitt JB, Tarwater PM, Zink MC. Dysregulation of mitogen-activated protein kinase signaling pathways in simian immunodeficiency virus encephalitis. Am J Pathol 2004; 164: 355–362
   Google Scholar
• Borderie D, Hernvann A, Hilliquin P, Lemarchal H, Kahan A, Ekindjian OG. Tetracyclines inhibit nitrosothiol production by cytokine-stimulated osteoarthritic synovial cells. Inflamm Res 2001; 50: 409–414
   Google Scholar
• Borsello T, Forloni G. JNK signalling: a possible target to prevent neurodegeneration. Curr Pharm Des 2007; 13: 1875–1886
   PubMed Web of Science ®Google Scholar
• Boven LA, Gomes L, Hery C, Gray F, Verhoef J, Portegies P, Tardieu M, Nottet HS. Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection. J Immunol 1999; 162: 4319–4327
   PubMedGoogle Scholar
• Brigham and Women's Hospital. A study of the effects of minocycline on cognitive function after carotid endarterectomy. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (USA). 2000. [Accessed Feb. 1, 2008.] Available at http://clinicaltrials.gov/ct/show/NCT00401921 NLM Identifier: NCT00401921.
   Google Scholar
• Brook M, Sully G, Clark AR, Saklatvala J. Regulation of tumour necrosis factor alpha mRNA stability by the mitogen-activated protein kinase p38 signalling cascade. FEBS Lett 2000; 483: 57–61
   PubMedGoogle Scholar
• Bukrinsky MI, Nottet HS, Schmidtmayerova H, Dubrovsky L, Flanagan CR, Mullins ME, Lipton SA, Gendelman HE. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J Exp Med 1995; 181: 735–745
   PubMed Web of Science ®Google Scholar
• Diguet E, Fernagut PO, Wei X, Du Y, Rouland R, Gross C, Bezard E, Tison F. Deleterious effects of minocycline in animal models of Parkinson's disease and Huntington's disease. Eur J Neurosci 2004; 19: 3266–3276
   PubMed Web of Science ®Google Scholar
• Dore GJ, McDonald A, Li Y, Kaldor JM, Brew BJ. Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 2003; 17: 1539–1545
   PubMed Web of Science ®Google Scholar
• Dorion S, Lambert H, Landry J. Activation of the p38 signaling pathway by heat shock involves the dissociation of glutathione S-transferase Mu from Ask1. J Biol Chem 2002; 277: 30792–30797
   PubMed Web of Science ®Google Scholar
• Duncan AJ, Heales SJ. Nitric oxide and neurological disorders. Mol Aspects Med 2005; 26: 67–96
   PubMedGoogle Scholar
• Elewa HF, Hilali H, Hess DC, Machado LS, Fagan SC. Minocycline for short-term neuroprotection. Pharmacotherapy 2006; 26: 515–521
   PubMed Web of Science ®Google Scholar
• EMD Serono. Minocycline as Add-on to Interferon-Beta-1a (Rebif®) in RRMS (Recycline). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000. [Accessed Feb 1, 2008.] Available at http://clinicaltrials.gov/ct/show/NCT00381459 NLM Identifier: NCT00381459.
   Google Scholar
• Gordon PH, Moore DH, Miller RG, Florence JM, Verheijde JL, Doorish C, Hilton JF, Spitalny GM, MacArthur RB, Mitsumoto H, Neville HE, Boylan K, Mozaffar T, Belsh JM, Ravits J, Bedlack RS, Graves MC, McCluskey LF, Barohn RJ, Tandan R. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol 2007; 6: 1045–1053
   PubMed Web of Science ®Google Scholar
• Guo X, Gerl RE, Schrader JW. Defining the involvement of p38alpha MAPK in the production of anti- and proinflammatory cytokines using an SB 203580-resistant form of the kinase. J Biol Chem 2003; 278: 22237–22242
   PubMedGoogle Scholar
• Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo?. FEBS Lett 1997; 411: 157–160
   PubMed Web of Science ®Google Scholar
• Han OJ, Joe KH, Kim SW, Lee HS, Kwon NS, Baek KJ, Yun HY. Involvement of p38 mitogen-activated protein kinase and apoptosis signal-regulating kinase-1 in nitric oxide-induced cell death in PC12 cells. Neurochem Res 2001; 26: 525–532
   Google Scholar
• Harper SJ, LoGrasso P. Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38. Cell Signal 2001; 13: 299–310
   PubMed Web of Science ®Google Scholar
• Hayakawa T, Matsuzawa A, Noguchi T, Takeda K, Ichijo H. The ASK1-MAP kinase pathways in immune and stress responses. Microbes Infect 2006; 8: 1098–1107
   PubMed Web of Science ®Google Scholar
• He Y, Zhang W, Zhang R, Zhang H, Min W. SOCS1 inhibits tumor necrosis factor-induced activation of ASK1-JNK inflammatory signaling by mediating ASK1 degradation. J Biol Chem 2006; 281: 5559–5566
   PubMed Web of Science ®Google Scholar
• Hershko T, Korotayev K, Polager S, Ginsberg D. E2F1 modulates p38 MAPK phosphorylation via transcriptional regulation of ASK1 and Wip1. J Biol Chem 2006; 281: 31309–31316
   PubMed Web of Science ®Google Scholar
• Huntington Study Group, FDA Office of Orphan Products Development. Pilot Study of Minocycline in Huntington's Disease. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000. [Accessed Feb 1, 2008.] Available at http://clinicaltrials.gov/ct/show/NCT00277355 NLM Identifier: NCT00277355.
   Google Scholar
• Hwang JR, Zhang C, Patterson C. C-terminus of heat shock protein 70-interacting protein facilitates degradation of apoptosis signal-regulating kinase 1 and inhibits apoptosis signal-regulating kinase 1-dependent apoptosis. Cell Stress Chaperones 2005; 10: 147–156
   PubMed Web of Science ®Google Scholar
• Jackson AC, Scott CA, Owen J, Weli SC, Rossiter JP. Therapy with minocycline aggravates experimental rabies in mice. J Virol 2007; 81: 6248–6253
   Google Scholar
• Jibiki I, Hashimoto S, Maruoka S, Gon Y, Matsuzawa A, Nishitoh H, Ichijo H, Horie T. Apoptosis signal-regulating kinase 1-mediated signaling pathway regulates nitric oxide-induced activator protein-1 activation in human bronchial epithelial cells. Am J Respir Crit Care Med 2003; 167: 856–861
   Google Scholar
• Kadowaki H, Nishitoh H, Urano F, Sadamitsu C, Matsuzawa A, Takeda K, Masutani H, Yodoi J, Urano Y, Nagano T, Ichijo H. Amyloid beta induces neuronal cell death through ROS-mediated ASK1 activation. Cell Death Differ 2005; 12: 19–24
   PubMed Web of Science ®Google Scholar
• Kraus RL, Pasieczny R, Lariosa-Willingham K, Turner MS, Jiang A, Trauger JW. Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity. J Neurochem 2005; 94: 819–827
   PubMed Web of Science ®Google Scholar
• Kutuzov MA, Andreeva AV, Voyno-Yasenetskaya TA. Regulation of apoptosis signal-regulating kinase 1 degradation by G{alpha}13. FASEB J 2007; 21: 3727–3726
   Google Scholar
• Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994; 372: 739–746
   PubMed Web of Science ®Google Scholar
• Liu Y, Min W. Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner. Circ Res 2002; 90: 1259–1266
   PubMed Web of Science ®Google Scholar
• Michaelis M, Kleinschmidt MC, Doerr HW, Cinatl J, Jr. Minocycline inhibits West Nile virus replication and apoptosis in human neuronal cells. J Antimicrob Chemother 2007; 60: 981–986
   PubMed Web of Science ®Google Scholar
• Mielke K, Herdegen T. JNK and p38 stresskinases--degenerative effectors of signal-transduction-cascades in the nervous system. Prog Neurobiol 2000; 61: 45–60
   PubMed Web of Science ®Google Scholar
• Mievis S, Levivier M, Communi D, Vassart G, Brotchi J, Ledent C, Blum D. Lack of minocycline efficiency in genetic models of Huntington's disease. Neuromolecular Med 2007; 9: 47–54
   PubMed Web of Science ®Google Scholar
• Mishra MK, Basu A. Minocycline neuroprotects, reduces microglial activation, inhibits caspase-3 induction, and viral replication following Japanese Encephalitis. J Neurochem 2008; 105: 1582–1595
   PubMed Web of Science ®Google Scholar
• Morimoto N, Shimazawa M, Yamashima T, Nagai H, Hara H. Minocycline inhibits oxidative stress and decreases in vitro and in vivo ischemic neuronal damage. Brain Res 2005; 1044: 8–15
   Google Scholar
• Morishima Y, Gotoh Y, Zieg J, Barrett T, Takano H, Flavell R, Davis RJ, Shirasaki Y, Greenberg ME. Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J Neurosci 2001; 21: 7551–7560
   PubMed Web of Science ®Google Scholar
• Nagai H, Noguchi T, Takeda K, Ichijo H. Pathophysiological roles of ASK1-MAP kinase signaling pathways. J Biochem Mol Biol 2007; 40: 1–6
   PubMedGoogle Scholar
• National Institute of Allergy and Infectious Diseases, Neuologic AIDS Research Consortium. Minocycline for the Treatment of Decreased Mental Function in HIV Infected Adults In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000. National Library of Medicine (US). 2000. [Accessed Feb 1, 2008.] Available at http://clinicaltrials.gov/ct/show/NCT00361257 NLM Identifier: NCT00361257.
   Google Scholar
• National Institute of Mental Health. Minocycline to Treat Childhood Regressive Autism. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000. [Accessed Feb 1, 2008.] Available at http://clinicaltrials.gov/ct/show/NCT00409747 NLM Identifier: NCT00409747.
   Google Scholar
• Nikodemova M, Duncan ID, Watters JJ. Minocycline exerts inhibitory effects on multiple mitogen-activated protein kinases and IkappaBalpha degradation in a stimulus-specific manner in microglia. J Neurochem 2006; 96: 314–323
   PubMed Web of Science ®Google Scholar
• Ouyang M, Shen X. Critical role of ASK1 in the 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells. J Neurochem 2006; 97: 234–244
   PubMed Web of Science ®Google Scholar
• Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007; 87: 315–424
   PubMed Web of Science ®Google Scholar
• Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, McArthur JC, Collier AC, Evans SR, Ellis RJ. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 2007; 21: 1915–1921
   PubMed Web of Science ®Google Scholar
• Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L. HIV-associated cognitive impairment before and after the advent of combination therapy. J NeuroVirol 2002; 8: 136–142
   PubMed Web of Science ®Google Scholar
• Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 1998; 17: 2596–2606
   PubMed Web of Science ®Google Scholar
• Sapadin AN, Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 2006; 54: 258–265
   PubMed Web of Science ®Google Scholar
• Sarchielli P, Galli F, Floridi A, Floridi A, Gallai V. Relevance of protein nitration in brain injury: a key pathophysiological mechanism in neurodegenerative, autoimmune, or inflammatory CNS diseases and stroke. Amino Acids 2003; 25: 427–436
   PubMed Web of Science ®Google Scholar
• Sarker KP, Biswas KK, Rosales JL, Yamaji K, Hashiguchi T, Lee KY, Maruyama I. Ebselen inhibits NO-induced apoptosis of differentiated PC12 cells via inhibition of ASK1-p38 MAPK-p53 and JNK signaling and activation of p44/42 MAPK and Bcl-2. J Neurochem 2003; 87: 1345–1353
   PubMed Web of Science ®Google Scholar
• Sekine Y, Takeda K, Ichijo H. The ASK1-MAP kinase signaling in ER stress and neurodegenerative diseases. Curr Mol Med 2006; 6: 87–97
   PubMed Web of Science ®Google Scholar
• Stirling DP, Koochesfahani KM, Steeves JD, Tetzlaff W. Minocycline as a neuroprotective agent. Neuroscientist 2005; 11: 308–322
   PubMed Web of Science ®Google Scholar
• Sumbayev VV. S-nitrosylation of thioredoxin mediates activation of apoptosis signal-regulating kinase 1. Arch Biochem Biophys 2003; 415: 133–136
   Google Scholar
• Takeda K, Noguchi T, Naguro I, Ichijo H. Apoptosis signal-regulating kinase 1 in stress and immune response. Annu Rev Pharmacol Toxicol 2008; 48: 199–225
   PubMed Web of Science ®Google Scholar
• Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T, Ichijo H. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2001; 2: 222–228
   PubMed Web of Science ®Google Scholar
• Tobiume K, Saitoh M, Ichijo H. Activation of apoptosis signal-regulating kinase 1 by the stress-induced activating phosphorylation of pre-formed oligomer. J Cell Physiol 2002; 191: 95–104
   PubMed Web of Science ®Google Scholar
• Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF, Visco-Comandini U, Vlassi C, Giulianelli M, Galgani S, Antinori A, Narciso P. Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr 2007; 45: 174–182
   PubMed Web of Science ®Google Scholar
• Tsuji M, Wilson MA, Lange MS, Johnston MV. Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model. Exp Neurol 2004; 189: 58–65
   PubMed Web of Science ®Google Scholar
• Vincent VA, De Groot CJ, Lucassen PJ, Portegies P, Troost D, Tilders FJ, Van Dam AM. Nitric oxide synthase expression and apoptotic cell death in brains of AIDS and AIDS dementia patients. AIDS 1999; 13: 317–326
   Google Scholar
• Wang SW, Pawlowski J, Wathen ST, Kinney SD, Lichenstein HS, Manthey CL. Cytokine mRNA decay is accelerated by an inhibitor of p38-mitogen-activated protein kinase. Inflamm Res 1999; 48: 533–538
   PubMed Web of Science ®Google Scholar
• Whiteman M, Halliwell B. Prevention of peroxynitrite-dependent tyrosine nitration and inactivation of alpha1-antiproteinase by antibiotics. Free Radic Res 1997; 26: 49–56
   PubMed Web of Science ®Google Scholar
• Wilkins A, Nikodemova M, Compston A, Duncan I. Minocycline attenuates nitric oxide-mediated neuronal and axonal destruction in vitro. Neuron Glia Biology 2004; 1: 297–305
   Google Scholar
• Wright EK, Jr, Clements JE, Barber SA. Sequence variation in the CC-chemokine ligand 2 promoter of pigtailed macaques is not associated with the incidence or severity of neuropathology in a simian immunodeficiency virus model of human immunodeficiency virus central nervous system disease. J NeuroVirol 2006; 12: 411–419
   PubMed Web of Science ®Google Scholar
• Yen PK, Shaw JH. Minocycline and its influence on calcifying tissues of young monkeys. J Dent Res 1975; 54: 423
   Google Scholar
• Zhang Q, Zhang G. Activation and autophosphorylation of apoptosis signal-regulating kinase 1 (ASK1) following cerebral ischemia in rat hippocampus. Neurosci Lett 2002; 329: 232–236
   PubMed Web of Science ®Google Scholar
• Zink MC, Suryanarayana K, Mankowski JL, Shen A, Piatak M, Jr, Spelman JP, Carter DL, Adams RJ, Lifson JD, Clements JE. High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J Virol 1999; 73: 10480–10488
   PubMed Web of Science ®Google Scholar
• Zink MC, Uhrlaub J, DeWitt J, Voelker T, Bullock B, Mankowski J, Tarwater P, Clements J, Barber S. Neuroprotective and anti-human immunodeficiency virus activity of minocycline. JAMA 2005; 293: 2003–2011
   PubMed Web of Science ®Google Scholar